Walleye Capital’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177K | Sell |
3,323
-69,661
| -95% | -$3.72M | ﹤0.01% | 1414 |
|
|
2025
Q1 | $2.95M | Sell |
72,984
-61,721
| -46% | -$2.5M | 0.01% | 501 |
|
|
2024
Q4 | $3.75M | Buy |
+134,705
| New | +$3.75M | 0.01% | 516 |
|
|
2024
Q3 | – | Sell |
-23,707
| Closed | -$556K | – | 2448 |
|
|
2024
Q2 | $556K | Buy |
23,707
+12,627
| +114% | +$296K | ﹤0.01% | 1408 |
|
|
2024
Q1 | $280K | Sell |
11,080
-118,937
| -91% | -$3M | ﹤0.01% | 1669 |
|
|
2023
Q4 | $3.04M | Buy |
+130,017
| New | +$3.04M | 0.01% | 504 |
|
|
2023
Q3 | – | Sell |
-59,677
| Closed | -$2.79M | – | 2228 |
|
|
2023
Q2 | $2.79M | Sell |
59,677
-45,755
| -43% | -$2.14M | 0.01% | 419 |
|
|
2023
Q1 | $4.03M | Buy |
105,432
+15,864
| +18% | +$607K | 0.06% | 344 |
|
|
2022
Q4 | $4.91M | Sell |
89,568
-114,475
| -56% | -$6.27M | 0.09% | 257 |
|
|
2022
Q3 | $6.95M | Buy |
+204,043
| New | +$6.95M | 0.13% | 155 |
|